UNH$302.41▼ -1.2%
DOCS$44.18▲ +0.8%
BRBR$52.33▼ -0.4%
SAFE$16.92▲ +1.1%
NVO$81.50▼ -0.6%
S&P 5005,770▼ -0.3%
NASDAQ18,210▲ +0.2%
GOLD$2,918▲ +0.5%
UNH$302.41▼ -1.2%
DOCS$44.18▲ +0.8%
BRBR$52.33▼ -0.4%
SAFE$16.92▲ +1.1%
NVO$81.50▼ -0.6%
S&P 5005,770▼ -0.3%
NASDAQ18,210▲ +0.2%
GOLD$2,918▲ +0.5%
Live · Updated Weekly

Equity Research
Made Simple

Plain-language stock analysis for everyone — no finance degree required. We cut through the noise so you can invest with confidence.

10+
Active Reports
100%
Plain Language
10min
Reads
Free
Always
Our Research
Recent Reports — Stocks to Watch
Hover any card to see key metrics · Click to read full report
UNH
UnitedHealth Group
Healthcare · Insurance
CAUTION
UNH · HEALTHCARE
MCR at 89.9% — EPS cut 4× from $29.50 to $16.25. CEO replaced. Recovery by 2027.
89.9%
Med Cost Ratio
$450B
2025 Revenue
Full Report
NVO
Novo Nordisk
Pharma · GLP-1
WATCH
NVO · PHARMA
GLP-1 leader under pressure from competitors. Ozempic & Wegovy remain dominant. Valuation reset creating opportunity.
32%
Rev Growth
~26×
P/E
Full Report
BRBR
BellRing Brands
Consumer · Nutrition
WAIT
BRBR · CONSUMER
Premier Protein RTD share fell 500bps. Class action filed. Channel destocking ongoing. Brand intact — 2 clean quarters needed.
-500
bps mkt share
#1
RTD Protein
Full Report
SAFE
Safehold Inc.
REIT · Ground Lease
INCOME
SAFE · REIT
Only public ground lease REIT. Trading at 0.41× book. $220M new originations Q2 2025. 5.23% dividend while you wait.
0.41×
Price/Book
5.23%
Dividend
Full Report
CPRX
Catalyst Pharma
Pharma · Rare Disease
WAIT
CPRX · PHARMA
Cheap at 13.65× P/E but Hetero patent trial (Mar 2026) is binary risk for FIRDAPSE — its core revenue driver.
20/30
BQ Score
44%
Op Margin
Full Report
HALO
Halozyme Therapeutics
Pharma · Drug Delivery
WATCH
HALO · PHARMA
Royalty engine for 20+ pharma giants. Fwd P/E 8.28× but ENHANZE patents expire 2027–29.
62%
Op Margin
45.7%
ROIC
Full Report
EPRT
Essential Properties
REIT · Net Lease
INCOME
EPRT · REIT
99.8% occupancy across 2,266 properties. FFO growing 6–14% per quarter. 4.05% dividend yield.
99.8%
Occupancy
4.05%
Dividend
Full Report
HUM
Humana
Healthcare · Insurance
TRACK
HUM · HEALTHCARE
Benefit ratio hit 91.1% in Q3 2025. Star rating degradation cutting bonuses. Wait for margin recovery.
91.1%
Benefit Ratio
$423
52W High
Full Report
CNC
Centene
Healthcare · Insurance
CAUTION
CNC · HEALTHCARE
Stock -53% from highs. $6.7B goodwill impairment. HBR hit 93% in Q2 2025. ACA subsidy policy is the key swing factor.
93%
HBR Q2 2025
$98.53
52W High
Full Report
MOH
Molina Healthcare
Healthcare · Managed Care
WATCH
MOH · HEALTHCARE
Contract wins support revenue. EPS guidance cut 26% in 2025. $1B buyback. Michael Burry bought in Q3 2025.
11×
P/E (Best in peer)
$1B
Buyback 2025
Full Report
Market Updates
Current News
Click any headline to expand
UNH
MCR hits 89.9% — EPS guidance cut 4× in 2025, CEO replaced, DOJ investigation ongoing
Mar 2026
UNH
Breaking
Medical Cost Ratio surged to 89.9% vs 83–85% historical norm. EPS guidance cut from $29.50 → $16.25. DOJ investigation ongoing. Management guides double-digit recovery from 2027 — requires MCR stabilisation, DOJ resolution, and Optum restructuring simultaneously.
Read Full UNH Report →
DOCS
Pharma budget freeze hits Doximity — Q4 revenue guided at just +4% growth
Mar 2026
DOCS
Watch
16 of top 20 pharma companies signed MFN agreements, causing delayed bookings. Q4 guided at +4% vs +23% in Q2. Moat intact: 117% revenue retention, #1 ROIC of 47 peers. All AI revenue excluded from guidance — low bar that could be materially beaten.
Read Full DOCS Report →
BRBR
Class action filed — channel destocking hits core shakes revenue for first time
Feb 2026
BRBR
Caution
Premier Protein RTD market share fell 500bps to 25%. Securities class action filed. Core shakes revenue turned negative for first time. Brand remains #1 in RTD protein — channel reset, not collapse. GLP-1 tailwind structural. Two clean quarters needed before re-entry.
Read Full BRBR Report →
SAFE
Only public ground lease REIT at 0.41× book — $220M new originations in Q2 2025
Mar 2026
SAFE
Income
Safehold closed $220M in new originations in Q2 2025. Net margin improved from 29.3% → 30.4%. Stock at 0.41× book — P/E #1 of 17 REIT peers — because rising rates compressed long-duration lease values. The 5.23% dividend pays while waiting for rate-driven re-rating.
Read Full SAFE Report →
Education
Articles
Plain-language explainers on investing, markets, and the companies we cover
Methodology
The BQ Score Explained — How We Rate Business Quality
Five parameters. One score out of 30. How we measure whether a business is genuinely getting stronger year on year.
7 min · Original Research
Fundamentals
The Gold Medal Problem — Why Cash Often Wins Over Profit
P/E shows the story. Free Cash Flow shows whether it's real. The Mumbai bazaar that explains everything.
6 min · Beginner
Macro · Commodities
GOLD — The Barometer of Fear and Uncertainty
Five thousand years of history, one signal. When gold rises, the world is afraid. Why $5,000/oz matters now.
5 min · Intermediate
Healthcare · Case Study
What If UNH Today Is Like MRF in February 2025?
A global giant facing a short-term reset, not a collapse. The Indian parallel every investor should know.
5 min · Intermediate
Investing · Beginner
Plant a Mango Seed, Not a Gamble
Why patience beats hype every time. The Titan vs Yes Bank story every new investor needs to read first.
5 min · Beginner
Macro · Tech
From Moon Dust to Data Points — The Age of AI Advertising
We went to the moon. Then built an algorithm to sell you running shoes. What this means for investors.
6 min · Intermediate